Diabetes mellitus: Pathology review

1,381,367views

Diabetes mellitus: Pathology review

Fysio Review

Fysio Review

Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Agonist, partial agonist and antagonist
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug elimination and clearance
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Glycolysis
Liver anatomy and physiology
Body temperature regulation (thermoregulation)
Olfactory transduction and pathways
Neuromuscular junction and motor unit
Anatomy and physiology of the eye
Photoreception
Blood pressure, blood flow, and resistance
Microcirculation and Starling forces
Neuron action potential
Menopause
Progestins and antiprogestins
Estrogens and antiestrogens
Renin-angiotensin-aldosterone system
Baroreceptors
Chemoreceptors
Cardiac conduction system
ECG basics
Pressures in the cardiovascular system
Resistance to blood flow
Measuring cardiac output (Fick principle)
Stroke volume, ejection fraction, and cardiac output
Cardiac contractility
Frank-Starling relationship
Cardiac preload
Cardiac afterload
Law of Laplace
Cardiac and vascular function curves
Altering cardiac and vascular function curves
Cardiac cycle
Pressure-volume loops
Changes in pressure-volume loops
Cardiac work
Physiological changes during exercise
Excitability and refractory periods
Action potentials in myocytes
Action potentials in pacemaker cells
ECG normal sinus rhythm
Endocrine system anatomy and physiology
Hunger and satiety
Adrenocorticotropic hormone
Oxytocin and prolactin
Antidiuretic hormone
Thyroid hormones
Insulin
Cortisol
Estrogen and progesterone
Testosterone
Parathyroid hormone
Phosphate, calcium and magnesium homeostasis
Calcitonin
Vitamin D
Anatomy and physiology of the ear
Auditory transduction and pathways
Vestibulo-ocular reflex and nystagmus
Taste and the tongue
Gastrointestinal system anatomy and physiology
Enteric nervous system
Gastric motility
Chewing and swallowing
Carbohydrates and sugars
Fats and lipids
Proteins
Pancreatic secretion
Bile secretion and enterohepatic circulation
Blood components
Erythropoietin
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Complement system
Innate immune system
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of natural killer and CD8 cells
Cell-mediated immunity of CD4 cells
Antibody classes
Somatic hypermutation and affinity maturation
B- and T-cell memory
Bone remodeling and repair
Muscular system anatomy and physiology
Slow twitch and fast twitch muscle fibers
Muscle contraction
Nervous system anatomy and physiology
Ascending and descending spinal tracts
Pyramidal and extrapyramidal tracts
Muscle spindles and golgi tendon organs
Somatosensory receptors
Somatosensory pathways
Sympathetic nervous system
Adrenergic receptors
Cholinergic receptors
Parasympathetic nervous system
Basal ganglia: Direct and indirect pathway of movement
Memory
Sleep
Learning
Body fluid compartments
Movement of water between body compartments
Hydration
Glomerular filtration
Regulation of renal blood flow
Urea recycling
Tubular reabsorption of glucose
Tubular reabsorption and secretion of weak acids and bases
Proximal convoluted tubule
Loop of Henle
Distal convoluted tubule
Sodium homeostasis
Osmoregulation
Buffering and Henderson-Hasselbalch equation
Physiologic pH and buffers
The role of the kidney in acid-base balance
Acid-base map and compensatory mechanisms
Respiratory acidosis
Metabolic acidosis
Plasma anion gap
Respiratory alkalosis
Metabolic alkalosis
Puberty and Tanner staging
Anatomy and physiology of the female reproductive system
Anatomy and physiology of the male reproductive system
Pregnancy
Respiratory system anatomy and physiology
Lung volumes and capacities
Alveolar surface tension and surfactant
Ventilation
Airflow, pressure, and resistance
Gas exchange in the lungs, blood and tissues
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Carbon dioxide transport in blood
Pulmonary chemoreceptors and mechanoreceptors
Breathing control
Pulmonary changes at high altitude and altitude sickness
Pulmonary changes during exercise
Parkinson disease
Anti-parkinson medications
Restrictive lung diseases
Arterial disease
Huntington disease
Introduction to pharmacology
Pharmacokinetics: Drug metabolism
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Sympathomimetics: Direct agonists
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Beta blockers
Adrenergic antagonists: Alpha blockers
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Monoamine oxidase inhibitors
Atypical antidepressants
Typical antipsychotics
Atypical antipsychotics
Lithium
Nonbenzodiazepine anticonvulsants
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Psychomotor stimulants
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Positive inotropic medications
Hypoglycemics: Insulin secretagogues
Insulins
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Hyperthyroidism medications
Acid reducing medications
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Thrombolytics
Glucocorticoids
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Migraine medications
General anesthetics
Local anesthetics
Neuromuscular blockers
Medications for neurodegenerative diseases
Opioid antagonists
Osmotic diuretics
Carbonic anhydrase inhibitors
Loop diuretics
Potassium sparing diuretics
Androgens and antiandrogens
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Alcohol use disorder
Substance misuse and addiction: Clinical
Gluconeogenesis
Hypertension: Clinical
Tobacco use disorder
Anemia: Clinical
Metabolic and respiratory acidosis: Clinical
Breathing cycle and regulation
Bipolar and related disorders
Schizophrenia
Amnesia
Attention deficit hyperactivity disorder
Diabetes mellitus
Diabetes mellitus: Clinical
Diabetes mellitus: Pathology review
Hypertension
Dyslipidemias: Pathology review
Ischemic stroke

Transcript

Watch video only

In the Emergency Department, two individuals came in. One of them is 12-year-old Timmy, who is severely dehydrated, presents with rapid and deep breaths, abdominal pain, nausea and vomiting. On the clinical examination, his breath actually smells fruity and sweet. Timmy’s parents said that he had been eating a lot lately, but he actually lost weight. Also, they said that Timmy is also drinking water all the time and going to the bathroom a lot. The other person is 55-year-old Oliver, who also came in with severe dehydration, lethargy; and his family said he had a seizure about 2 hours ago, and in the past month, he had lost some weight, although he had been eating. Both individuals underwent several investigations, including glucose levels, ketones, BMP, and an ABG. Okay, based on both individuals’ symptoms, we can assume that both suffer from diabetes mellitus.

Diabetes mellitus is a condition where glucose can’t be properly moved from the blood into the cells. This leads to high levels of glucose in the blood and not enough of it inside cells. Since cells need glucose as a source of energy, not letting glucose enter means that the cells starve for energy despite having glucose right on their doorstep.

In general, the body controls how much glucose is in the blood with two hormones: insulin and glucagon. Both of these hormones are produced in the islets of Langerhans of the pancreas. Insulin is secreted by the beta cells, while glucagon is secreted by the alpha cells.

Insulin reduces blood glucose levels. It does that by binding to insulin receptors embedded in the cell membrane of insulin-responsive tissues, like muscle cells and adipose tissue. When activated, the insulin receptors cause vesicles containing glucose transporter that are inside the cell to fuse with the cell membrane, allowing glucose to be transported into the cell.

Okay, now, there are two types of diabetes mellitus, Type 1 and Type 2, and the main difference between them is the underlying mechanism that causes the blood glucose levels to rise.

Let’s start with Type 1 diabetes mellitus, which is an autoimmune condition. See, autoimmune conditions sometimes happen together. So on the exam, the past medical history might include a history of autoimmune thyroid disease like Hashimoto’s thyroiditis or vitiligo or lupus.

In type 1 diabetes, the immune system targets and destroys the beta-cells of the pancreas. A common target is an enzyme inside beta cells called glutamic acid decarboxylase, which helps make gamma aminobutyric acid or GABA, which, among others, increases insulin release and also has a protective and regenerative effect on the beta-cells. The high yield fact to remember is that the antibodies against glutamic acid decarboxylase are called GAD antibodies.

In addition, other antibodies like anti-islet cell antibodies can also be present. Without the protective and regenerative effect of GABA, the beta cells progressively decrease. Losing beta cells means less insulin, and less insulin means that glucose builds up in the blood, because it can’t enter the body’s cells.

Now, there is a gene complex involved in the regulation of the immune response, and this is called the human leukocyte antigen system, or HLA system. These genes code for the major histocompatibility complex, or MHC, which is a protein that’s extremely important in helping the immune system recognize foreign molecules, as well as maintaining self-tolerance. MHC is like the serving platter where antigens are presented to the immune cells. Interestingly, people with type 1 diabetes often have specific HLA genes in common; HLA-DR3 and HLA-DR4, both of which are high yield for your exams.

In diabetes mellitus type 1, destruction of beta cells usually starts early in life and individuals present with symptoms of diabetes before the age of 30. In type 1 diabetes, the tissues are very sensitive to insulin, but since there are less beta-cells, insulin levels are low. On histology, there is usually an islet leukocytic infiltrate.

There are four clinical symptoms of uncontrolled diabetes; there’s polyphagia, glucosuria, polyuria, and polydipsia. Let’s go through them one by one. Even though there’s a lot of glucose in the blood, it can’t get into cells, which leaves cells starved for energy, so in response, adipose tissue starts breaking down fat, called lipolysis, and muscle tissue starts breaking down proteins, called proteolysis both of which results in weight loss for someone with uncontrolled diabetes. This catabolism leads to polyphagia.

Now with high glucose levels, when blood gets filtered through the kidneys, some of it starts to spill into the urine, and this is called glycosuria. Since glucose is osmotically active, water tends to follow it, resulting in an increase in urination, or polyuria. Finally, because there is so much urination, people with uncontrolled diabetes become dehydrated, resulting in polydipsia.

Now, let’s move on to Type 2 diabetes mellitus. In type 2 diabetes, the body makes insulin, but the tissues don’t respond as well to it. The exact reason why cells don’t “respond” isn’t fully understood; essentially the body’s providing the normal amount of insulin, but the cells don’t move their glucose transporters to the membrane. This is called insulin resistance.

The most important risk factor for insulin resistance is obesity. Apart from this, there are also some genetic factors involved. We see this when we look at twin studies as well, where having a twin with type 2 diabetes increases the risk of developing type 2 diabetes, completely independent of other environmental risk factors.

In Type 2 diabetes, since tissues don’t respond as well to normal levels of insulin, the body ends up producing more insulin in order to get the same effect and move glucose out of the blood. This works for a while, and by keeping insulin levels higher than normal, blood glucose levels can be kept normal. This beta cell compensation, though, isn’t sustainable, and over time these overworked beta cells get exhausted, and eventually die off. When this happens, insulin levels will start decreasing. So, remember that the serum levels of insulin in type 2 diabetes are variable, depending on when it’s diagnosed.

Now, along with insulin, beta cells also secrete islet amyloid polypeptide, so while beta cells are cranking out insulin they also secrete an increased amount of amyloid polypeptide. Over time, amyloid polypeptide builds up and aggregates in the islets, so on histology, there will be amyloid polypeptide deposits in the pancreas along with a variable number of beta-cells, depending on when it’s diagnosed.

Now, type 2 diabetes usually appears after the age of 40 and presents similarly to type 1 diabetes with polydipsia, polyuria, polyphagia and sometimes weight loss.

Diagnosing type 1 or type 2 diabetes is done by getting a sense of how much glucose is floating around in the blood. Very commonly, a fasting glucose test is taken where the person doesn’t eat or drink, except water, that’s okay, for 8 hours and has their blood tested for glucose levels. A Level of 126 milligrams per deciliter or higher indicates diabetes. A non-fasting or random glucose test can be done at any time, with 200 milligrams per deciliter or higher being diagnostic for diabetes if the individual has symptoms. Another test is called an oral glucose tolerance test, where a person is given glucose, and then blood samples are taken at time intervals to figure out how well it’s being cleared from the blood. A glucose level over 200 milligrams per deciliter after 2 hours indicates diabetes.

Okay, so when blood glucose levels get high, the glucose can also stick to proteins that are floating around in the blood or in cells. So that brings us to the HbA1c test, which tests for the proportion of hemoglobin in red blood cells that have glucose stuck to it, or glycated hemoglobin. HbA1c level of 6.5% or higher indicates diabetes. This proportion of glycated hemoglobin doesn’t change day to day, so a high yield fact is that this test gives a sense for whether the blood glucose levels have been high over the past 3 months, which is the lifespan of a typical red blood cell.

Regarding treatment, in type 1 diabetes, insulin is always necessary because of decreased endogenous production. While in type 2 diabetes, lifestyle modifications like exercise and dietary changes are first line. In addition, other medications like metformin, SGLT2 inhibitors, and GLP-1 receptor agonists are the first-line pharmacologic intervention in type 2 diabetes, with insulin being an option if other medications fail to control glucose levels. It’s also important to treat and prevent complications in diabetes. For example, ACE inhibitors and ARBs have been shown to decrease the risk of diabetic nephropathy in individuals with diabetes and hypertension. In addition, yearly eye exams, urine microalbumin testing, and foot exams should be done.

Now, let’s go over one very high yield acute complication of diabetes that usually happens with type 1 diabetes, and it’s called diabetic ketoacidosis, or DKA. This usually happens when individuals aren’t rigorous with their insulin therapy or when the body is really stressed and needs more insulin, like during an infection.

To understand it, let’s go back to the process of lipolysis, where fat is broken down into free fatty acids. After that happens, the liver turns the fatty acids into ketone bodies, like aceto-acetic acid and beta hydroxybutyric acid. These ketones are important because they can be used by cells for energy, but they also increase the acidity of the blood, which is why it’s called ketoacidosis, which is a type of metabolic acidosis. This doesn’t typically happen in type 2 diabetes because there’s usually some level of endogenous insulin that prevents lipolysis.

Clinically, individuals with DKA are dehydrated, because a lot of glucose is lost through urine and they can develop Kussmaul respiration, which is a deep and rapid breathing as the body tries to move carbon dioxide out of the blood in an effort to reduce its acidity. Their breath also smells sweet and fruity because ketones break down into acetone, which escapes as a gas during exhalation.

Abdominal pain, nausea, vomiting, and, in severe DKA, mental status changes like obtundation and coma can occur.

Complications of DKA include acute cerebral edema, which is when there’s too much fluid in the intra- or extracellular space. In the case of DKA, there’s too much fluid in the extracellular space of the brain because glucose basically drags water out of cells. Other complications include cardiac arrhythmias, due to potassium imbalance, which can lead to sudden cardiac death. Finally, since people with DKA have poorly controlled diabetes, their immune system is also likely to be compromised. This means they are more vulnerable to common infections like candida, but also some that only affect people with immune deficiencies. One of these is mucormycosis; a life-threatening fungal infection caused by Rhizopus species that starts in the sinuses but can spread to the brain.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Type 1 Diabetes Mellitus in Pediatrics" Pediatrics in Review (2008)
  4. "Hyperglycemic Crises in Adult Patients With Diabetes" Diabetes Care (2009)
  5. "Diabetes mellitus: definition, classification and diagnosis" Wien Klin Wochenschr (2016)